Potential new application points of SGLT2 inhibitors in patients with heart failure in combination with diabetes mellitus, non-alcoholic fatty liver disease and anemia (literature review)-Reference-Cited by-同舟云学术

Potential new application points of SGLT2 inhibitors in patients with heart failure in combination with diabetes mellitus, non-alcoholic fatty liver disease and anemia (literature review)

Published:2022-12-25 Issue:6 Volume:42 Page:4-14
ISSN:2410-2520
Container-title:Сибирский научный медицинский журнал
language:
Short-container-title:Sibirskij nauchnyj medicinskij zhurnal

Author:

Tsygankova O. V.¹^ORCID,Timoshchenko O. V.²^ORCID,Tuzovskaya O. V.²^ORCID,Latyntseva L. D.²^ORCID,Nikolaev K. Yu.²^ORCID

Affiliation:

1. Research Institute of Internal and Preventive Medicine – Branch of the Federal Research Center Institute of Cytology and Genetics SB RAS; Novosibirsk State Medical University of Minzdrav of Russia

2. Research Institute of Internal and Preventive Medicine – Branch of the Federal Research Center Institute of Cytology and Genetics SB RAS

Publisher

Institute of Cytology and Genetics, SB RAS

Reference57 articles.

1. Российское кардиологическое общество (РКО). Хроническая сердечная недостаточность. Клинические рекомендации 2020. Рос. кардиол. ж. 2020;25(11):4083. doi: 10.15829/1560-4071-2020- 4083 Russian Society of Cardiology (RSC). 2020. Clinical practice guidelines for chronic heart failure. Rossiyskiy kardiologicheskiy zhurnal = Russian Journal of Cardiology. 2020;25(11):4083. [In Russian]. doi: 10.15829/1560-4071-2020-4083

2. Redfield M.M. Heart failure with preserved ejection fraction. N. Engl. J. Med. 2016;375(19):1868– 1877. doi: 10.1056/NEJMcp1511175

3. Dunlay S.M., Roger V.L., Redfield M.M. Epidemiology of heart failure with preserved ejection fraction. Nat. Rev. Cardiol. 2017;14(10):591–602. doi: 10.1038/nrcardio.2017.65

4. Цыганкова О.В., Веретюк В.В. Фенотипические кластеры пациентов с хронической сердечной недостаточностью с сохраненной и промежуточной фракцией выброса: новые данные и перспективы. Рос. кардиол. ж. 2021;26(4):4436. doi: 10.15829/1560-4071-2021-4436 Tsygankova O.V., Veretyuk V.V. Phenotypic clusters in heart failure with preserved and mid-range ejection fraction: new data and perspectives. Rossiyskiy kardiologicheskiy zhurnal = Russian Journal of Cardiology. 2021;26(4):4436. [In Russian]. doi: 10.15829/1560- 4071-2021-4436

5. Цыганкова О.В., Веретюк В.В., Мареев В.Ю. Возможности положительной модификации кардиометаболического профиля при совместном назначении ангиотензиновых рецепторов-неприлизина ингибитора и эмпаглифлозина у коморбидных пациентов с хронической сердечной недостаточностью и сахарным диабетом 2 типа. Кардиология. 2020;60(5):146–152. doi: 10.18087/cardio.2020.5.n840 Tsygankova O.V., Veretyuk V.V., Mareev V.Yu. Modification of the of the cardiometabolic profile using combined therapy of the angiotensin receptor-neprilysin inhibitor and empagliflozin in comorbid patients with chronic heart failure and type 2 diabetes mellitus. Kardiologiya = Cardiology. 2020;60(5):146–152. [In Russian]. doi: 10.18087/cardio.2020.5.n840

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effect of a medicinal plant preparation on the frequency of episodes of exacerbation of recurrent cystitis and metabolic parameters in patients with type 2 diabetes mellitus taking glyphlosins;Terapevticheskii arkhiv;2023-10-11